Chase Therapeutics

Chase Therapeutics

Chase Therapeutics

Chase Therapeutics is an earlystage, productbased specialty pharmaceutical company focused on the development of better treatments for brain disease.
Raised
$4M
Follow us
Alexa global traffic share
Latest funding
$4,000,000
Venture capital (Series A) - 2018
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Chase Therapeutics makes some noise.